Research groups

Stem cells

The main aim of heart group is to differentiate functional cardiomyocytes and hepatocytes from pluripotent stem cells and study different genetic heart diseases and atherosclerosis with the help of induced pluripotent stem cell (iPSC) technology.

Group leader:
Prof. Katriina Aalto-Setälä

https://research.tuni.fi/heart-group/

Cardiac bioelectromechanics and in-silico modelling

Computational Biophysics and Imaging Group (CBIG) is part of Academy of Finland Centre of Excellence on Body on Chip Research.

Group leader:
Prof. Jari Hyttinen

https://research.tuni.fi/cbig/

Clinical Physiology

Research group’s activity focuses on the evaluation of cardiovascular function, hemodynamics and cardiometabolics in health and disease as well as better recognition of high-risk patient.

Group leader:
Prof. Mika Kähönen

https://research.tuni.fi/clinical-physiology

Clinical Research and Medical Biochemistry

Group leader:
Prof. Reijo Laaksonen

Group pages not available

Clinical Research; Cardiothoracic Surgery

Group leader:
Prof. Jari Laurikka

https://research.tuni.fi/cardiac-surgery/

Molecular Biology

Omics and atherosclerosis, Epigenetic inheritance

Group leader:
Prof. Terho Lehtimäki

https://research.tuni.fi/clinical-chemistry/

Molecular Epidemiology

The focus of the study group of Molecular Epidemiology is to investigate the link between molecular phenotypes, such as genetics, epigenetics and gene expression, and the development and onset of common chronic diseases.

Group leader:
Emma Raitoharju

https://www.tuni.fi/en/research/molecular-epidemiology-mole

Medical Biochemistry

We have priority to the Tampere adult population health risk (TAMRISK) material. This has been collected from the year 1980 and it comprises of approx. 40 000-person years of health follow-up, divided to age cohorts.

Group leader:
Prof. Seppo Nikkari

https://www.tuni.fi/en/research/medical-biochemistry

Tampere University Clinical Cardiology Research Group

The clinical cardiology research group is focused on two distinct areas of science: the clinical management of acute atrial tachyarrhythmias and the prediction and prevention of serious adverse events in patients with cardiac diseases.

Group leader:
Prof. Jussi Hernesniemi

Group pages not available

Molecular Biology; Clinical Research

Development of novel, unobtrusive sensor technology for the monitoring of vital signs and diagnostics cardiovascular diseases. Molecular Biology of atherosclerosis.Development of spatial imaging differential ion mobility spectrometry for high throughput analysis of atherosclerotic plaques.

Group leader:
Prof. Niku Oksala

https://www.tuni.fi/en/research/diagnose-extrasensory-olfactory-cues-status-wellbeing-2013-2015

Clinical Research

Group leader:
Prof. Ilkka Pörsti

Group pages not available

Monitoring and measurements

Our main interest is to develop more accurate and well-aimed non-invasive measurements and analysis methods for the detection of cardiopulmonary diseases and wound monitoring.

Group leader:
Prof. Jari Viik

https://research.tuni.fi/physiological-measurement-systems-and-methods/

Sensor Technology and Biomeasurements

Sensor Technology and Biomeasurements Group (STB) focuses on the research and development of embedded measurement technology for physiological monitoring and related signal processing and data analysis methods, mainly in the area of cardiovascular measurements. In addition, we study electronic nose techniques for clinical applications.

Group leader:
Assistant prof. Antti Vehkaoja

https://www.tuni.fi/en/research/sensor-technology-and-biomeasurements